Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Sep 1, 2026, 4:00 PM EDT
1.142
+0.012 (1.09%)
After-hours: Sep 1, 2026, 7:21 PM EDT
Sunshine Biopharma Employees
Sunshine Biopharma had 50 employees as of December 31, 2025. The number of employees decreased by 2 or -3.85% compared to the previous year.
Employees
50
Change (1Y)
-2
Growth (1Y)
-3.85%
Revenue / Employee
$706,935
Profits / Employee
-$116,653
Market Cap
4.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 50 | -2 | -3.85% | 50 | 0 |
| Dec 31, 2024 | 52 | 8 | 18.18% | 52 | 0 |
| Dec 31, 2023 | 44 | -2 | -4.35% | 44 | 0 |
| Dec 31, 2022 | 46 | 43 | 1,433.33% | 46 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 216 |
| cbdMD | 42 |
| BioXcel Therapeutics | 29 |
| RedHill Biopharma | 13 |
| InMed Pharmaceuticals | 13 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
| PRF Technologies | 7 |
SBFM News
- 1 day ago - Sunshine Biopharma announces Health Canada approval for atenolol - TheFly
- 1 day ago - Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Accesswire
- 4 days ago - Sunshine Biopharma files to sell 24.48M shares of common stock - TheFly
- 6 days ago - Sunshine Biopharma provides update, outlines plans for oncology project - TheFly
- 6 days ago - Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - Accesswire
- 13 days ago - Sunshine Biopharma receives Canadian regulatory approval for Enalapril - TheFly
- 13 days ago - Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Accesswire
- 25 days ago - Sunshine Biopharma launches generic amoxicillin formulation in Canada - TheFly